AbbVie Raises FY2026 Adj EPS Guidance from $13.76-$13.96 to $13.95-$13.99 vs $13.93 Est
AbbVie (NYSE:ABBV) raises FY2026 Adj EPS guidance from $13.76-$13.96 to $13.95-$13.99 vs $13.93 analyst estimate..
Share
Why It Matters
AbbVie raised its 2026 profit forecast slightly higher than before. When a company raises its forecast, it shows management feels confident about future business.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.